Praxis Precision Medicines logo

Praxis Precision Medicines

PRAX | NASDAQ
Chart Builder DCF Calculator
$310.27
-$17.86 (-5.44%)
At close: Nov 16, 2026, 4:00 PM ET
$312.14
+$1.87 (+0.60%)
After-hours: Nov 16, 2026, 7:31 PM ET
-5.44%

Rating

Updated: Nov 16, 2026
20.5
-0.2 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #988/1021 (Top 97%)

Key Statistics

Market Data

Market Cap $8.67B
1D Range
305.40 333.85
52W Range
164.09 386.33

Valuation (TTM)

PE -24.24
PB 6.89
EV/EBITDA -22.07

Valuation (NTM)

Forward PE N/A
Forward PEG -8.98
Price Target $595.50
Loading financial charts...

Profile

Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an ...

Sector Healthcare
Industry Biotechnology
Employees 168
IPO Date Oct 16, 2020
Fiscal Year January - December

Latest News

Praxis Precision Medicines, Inc. (PRAX) Presents at UBS Global Biopharma Conference 2026 Transcript

16 hours ago · seekingalpha.com

Praxis Precision Medicines, Inc. (PRAX) Presents at UBS Global Biopharma Conference 2026 Transcript
Praxis Precision Medicines: No Material Changes After Q3 And Investor Day (Rating Kept)

22 hours ago · seekingalpha.com

Praxis Precision Medicines: No Material Changes After Q3 And Investor Day (Rating Kept)
Praxis Precision Medicines, Inc. (PRAX) Presents at 3rd Annual Guggenheim Healthcare Innovation Conference Transcript

5 days ago · seekingalpha.com

Praxis Precision Medicines, Inc. (PRAX) Presents at 3rd Annual Guggenheim Healthcare Innovation Conference Transcript
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2026 Financial Results

8 days ago · globenewswire.com

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2026 Financial Results
Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation

20 days ago · globenewswire.com

Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation
Praxis: Commercial Launch Could Smash Expectations (Video)

3 months ago · seekingalpha.com

Praxis: Commercial Launch Could Smash Expectations (Video)
Praxis Precision Medicines, Inc. (PRAX) Q2 2026 Earnings Call Transcript

3 months ago · seekingalpha.com

Praxis Precision Medicines, Inc. (PRAX) Q2 2026 Earnings Call Transcript
Praxis Precision Medicines Q2 Earnings Call Highlights

3 months ago · marketbeat.com

Praxis Precision Medicines Q2 Earnings Call Highlights
Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

4 months ago · globenewswire.com

Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
Praxis Precision Medicines: Priced For Half Of What I Think It's Worth

4 months ago · seekingalpha.com

Praxis Precision Medicines: Priced For Half Of What I Think It's Worth

Earnings

Next Earnings
Feb 18, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
15
Consensus
Buy
Price Target
$616.00
Upside
+98.54%
Buy (13)
Hold (1)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.